Karla Knox v. HHS - Influenza, transverse myelitis (2022)
Case summary [AI summaries can sometimes make mistakes]
Karla Knox filed a petition under the National Vaccine Injury Compensation Program on December 28, 2021, alleging that she suffered from transverse myelitis (TM) as a result of an influenza vaccine received on March 13, 2018. The respondent denied that the flu vaccine caused Petitioner to develop TM or any other injury.
Despite these positions, both parties agreed to settle the case through a joint stipulation filed on December 28, 2021. Special Master Katherine E.
Oler reviewed the file and found the stipulation to be reasonable, adopting it as the court's decision. The stipulation awarded Petitioner a lump sum of $97,927.38, payable by check to Petitioner.
This award represents compensation for all damages available under the program, specifically referencing 42 U.S.C. § 300aa-15(a). The Special Master approved the award and directed that judgment be entered.
Ronald Homer of Conway Homer, P.C. represented the Petitioner, and Lynn Schlie of the U.S. Department of Justice represented the Respondent.
The decision was issued on February 18, 2022.
Theory of causation
Petitioner Karla Knox alleged that she suffered from transverse myelitis (TM) as a result of an influenza vaccine received on March 13, 2018. Respondent denied that the flu vaccine caused Petitioner's TM or any other injury. The parties reached a settlement via joint stipulation, agreeing to award Petitioner $97,927.38. The public decision does not detail the specific theory of causation, medical experts, clinical findings, or the mechanism by which the vaccine allegedly caused the injury. The award represents compensation for all damages available under 42 U.S.C. § 300aa-15(a). The decision was made by Special Master Katherine E. Oler on February 18, 2022, based on the stipulation. Petitioner was represented by Ronald Homer, and Respondent by Lynn Schlie.
Source PDFs
USCOURTS-cofc-1_20-vv-00067